Tuesday 20 December 2022
Dr. Reddy’s completes Phase 1 study of proposed biosimilar of tocilizumab
The proposed tocilizumab biosimilar is being developed as both subcutaneous and intravenous formulations, Dr. Reddy’s said
from The Hindu - Business
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment